Home 2018
Yearly Archives: 2018
Structured Family-Centered Peds Rounds Improve Patient Safety
Forty percent decrease seen in harmful errors; decrease also in nonpreventable adverse events
Pembrolizumab Promising for Metastatic Head, Neck SCC
Prolongs survival among patients with recurrent, metastatic head and neck squamous cell carcinoma
Hospitalization for Upper GI Bleed Highest With Rivaroxaban
Upper gastrointestinal bleeding hospitalization risk lower for anticoagulant tx with PPI cotherapy
Overlapping Orthopedic Surgery Noninferior for Patient Safety
Reduced odds of perioperative complications seen for overlapping surgery versus nonoverlapping surgery
Restrictive, Obstructive Lung Disease Linked to Dementia Risk
Associations seen for both Alzheimer's disease-related dementia and cerebrovascular etiologies
FDA Advisory Panels: Prescribe Naloxone With Opioid Painkillers
Federal government urged to make naloxone more widely available, easier to obtain, and cheaper
New Law Boosts Fight Against Sickle Cell Disease
In 2018, the National Institutes of Health was funded approximately $115 million for research of the disease
Modified-FOLFIRINOX Beneficial in Resected Pancreatic Cancer
Disease-free, overall survival significantly longer compared with gemcitabine, but more adverse events
Exercise Promotes Executive Functioning in Sedentary Adults
Significant improvements seen in executive functioning for those at risk for cognitive decline
Residential Greenness Linked to Cardiovascular Disease Risk
More greenness near residence linked to lower urinary levels of epinephrine and F2-isoprostane
